1. Pathogenesis and pharmacotherapy of Hidradenitis suppurativa;M Nazary;European Journal of Pharmacology,2011
2. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: A rationale for targeting TNF- α and IL-1β;HH Van Der Zee;Br J Dermatol,2011
3. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa;AB Kimball;N Engl J Med,2016
4. Immunogenicity of biologic agents in rheumatoid arthritis patients: Lessons for clinical practice;T Schaeverbeke;Rheumatology (United Kingdom),2015
5. The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis;S Garces;Ann Rheum Dis,2012